|
Naltrexone, Craving, and Drinking Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Naltrexone, Craving, and Drinking conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Naltrexone, Craving, and Drinking Clinical research trials and Naltrexone, Craving, and Drinking medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Naltrexone, Craving, and Drinking. Naltrexone, Craving, and Drinking Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Naltrexone, Craving, and Drinking clinical trial. Subjects often receive the most expert healthcare possible for their Naltrexone, Craving, and Drinking condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "N" Clinical Trials Conditions > Naltrexone, Craving, and Drinking  Naltrexone, Craving, and Drinking
Naltrexone, Craving, and Drinking
For Condition: Alcoholism
Status: Recruiting
Sponsor(s): National Institute on Alcohol Abuse and Alcoholism (NIAAA) ,
Synopsis: This 5-week study will examine the effects of naltrexone on alcohol craving, drinking rates, and reaction to drinking-related triggers, or cues, in participants' everyday environment and in laboratory sessions. Participants will monitor and record their daily desires to drink, environmental circumstances in which urges occur, and drinking behavior using a palm top computer. Participants will receive naltrexone or a placebo. One week after receiving medication, all participants will be asked to respond to alcohol-related cues that may or may not arouse the desire to drink.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Placebo Control, Efficacy Study
Minimum Age/Maximum Age: 21 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Drink at least 4 days per week with 2 heavy drinking days (more than 6 standard drinks for men, more than 5 drinks for women) per week on average during the month prior to the study. Exclusion Criteria: - Current interest in treatment or a history of treatment for alcohol problems. - History of liver disease or current liver function tests greater than five times normal. - Opiate abuse or dependence, any opiate use two weeks before the study or a urine test screen that is positive for opiates. - Females, who are pregnant, nursing, or not using reliable birth control method. - Daily use of acetaminophen. - Living with someone who participated in this study.
Total Enrollment: 186
Location and Contact Information:
Center for Alcohol and Addiction Studies, Brown University *Recruiting*
Providence, Rhode Island, 02919
United States
Recruiting Dr. Monti 401-444-1849
Additional Information:
Study ID Numbers: NIAAAMON0785011A1;
Study Start Date:
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006203
Other Alcoholism Studies:
1. Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits
2. Behavior and Naltrexone Treatment for Alcoholics
3. Drug Treatment for Alcoholics with Post-Traumatic Stress Disorder
4. Naltrexone for Relapse Prevention
5. Improving Substance Abuse Treatment Aftercare Adherence and Outcome
Related Studies:
Other Alcoholism Clinical Trials
Other Rhode Island Clinical Trials
Other Providence Clinical Trials
Naltrexone, Craving, and Drinking
|
|
|
|
|
|
|
|
